Company profile for LoQus23 Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At LoQus23, our expert team is taking a structure-based approach to mismatch repair drug discovery, investigating small molecule drugs that could stop DNA instability and therefore slow neurodegeneration in Huntington’s disease, myotonic dystrophy type 1 and similar triplet repeat expansion diseases. Oral small molecule drugs have a strong track record in treating complex brain diseases and provide greater convenience for pa...
At LoQus23, our expert team is taking a structure-based approach to mismatch repair drug discovery, investigating small molecule drugs that could stop DNA instability and therefore slow neurodegeneration in Huntington’s disease, myotonic dystrophy type 1 and similar triplet repeat expansion diseases. Oral small molecule drugs have a strong track record in treating complex brain diseases and provide greater convenience for patients compared with other treatment approaches.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Building 522 Babraham Research Campus Cambridge CB22 3AT
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/loqus23-therapeutics-announces-35-million-c43-million-series-a-financing-to-advance-its-small-molecule-somatic-expansion-inhibition-therapy-for-huntingtons-disease-302264555.html

PR NEWSWIRE
02 Oct 2024

https://www.prnewswire.com/news-releases/loqus23-therapeutics-appoints-dr-melanie-ivarsson-obe-as-non-executive-director-301465903.html

PRNEWSWIRE
24 Jan 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty